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was associated with increased mortality only among HF patients with LVEF @5%. 
Deaths due to arrhythmias and worsening HF contribute to the substantial mortality of 
patients wth LVEF>45% and may be targets for future interventions in this population. 
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In multlvarlate models, both LAD and LAVI remained independent predictors of stroke. 
LAVI (x2= 9.3, p=O.O02) was a powerful predictor, independent of age (x2=6.2. p=O.O13) 
and TIA k2=9.1, p=O.O02), adjusted for sex, hypertension, DM, and MI. A significant 
increment in risk (~~0.05) was found from quartile 1 to 2 of LAVI, and further from quartile 
3 to 4, while an increment in stroke risk was observed only from quartile 3 to 4 for LAD. 
Conclusions: LAVI is a powerful independent predictor of first stroke in older adults. It 
appears to be superior to LAD in the discrimination of stroke risk, even among the lower 
quarliks of LA size distribution, and thus may allow better stroke risk prediction and pre- 
vention. 
ii:15 a.m. 
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887FO-2 The Modifying Effect of Age on Risk Factors for Stroke: 
The Manitoba Follow-Up Study 
T. E. Cuddy, Robert B. Tate, Dennis J. Bayomi, T. K. Young, University of Manitoba. 
Winnipeg, MB, Canada 
Background: The Manitoba Follow-up Study, initiated in 1946, is a prospective investiga- 
tion of cardiovascular disease in a cohort of 3,963 men. The present investigation is the 
effect of age on traditional risk factors for stroke. 
Methods: Over a 50 year follow-up period physical examinations including blood pres- 
sure measurements and electrocardiograms have been recorded. Selected measure- 
ments from examinations at 5 year age intervals between 30 and 70 years of age for 
each man were related to the incidence of definite stroke and to all cerebrovascular 
events (definite stroke plus transient ischemic attacks) using Cox proportional hazard 
models (p-value set at 0.05 for risk factors). 
Results: During 163,933 person years of observation, a total of 552 men experienced 
cerebrovascular events, including 316 men with definite strokes. Across ages from 30 to 
70 years, significant risk ratios for definite stroke associated with a 10 mm Hg difference 
in SBP ranoed between 1.16 to 1.29 and between 1.26 to 1.50 for the same chanae in 
DBP. Risk ratios for diabetes mellitus ranged between 1.61 to 3.40, between 2.24 to3.11 
for atnal fibrillation and from a10 down to 1.56 for prior evidence of IHD. The nsk ratios 
for BPS were greatest between age 45 and 55 years. Age specific risk ratios were greater 
in models for definite strokes than in models for all cerebrovascular events. While the 
effects of these tradltional risk factors: blood pressure, atrial fibrillation and prior IHD 
decline in magnitude with age, the effect of smoking did not significantly vary with age, 
and remained statistically significant to age 70 years with risk ratios in the range of 1.46 
to 1.94. Body mass index, at any age, was not significantly associated with stroke. 
Conclusions: Recognition of the varying effect of these risk factors with age is important 
in the Identification of men at high risk for stroke. 
11:OOa.m. 
887FO-3 Prediction of First Stroke in Older Men and Women 
Without Atrial Fibrillation or Valvular Heart Disease 
Teresa S. Tsanq. Marion E. Barnes, Kent R. Bailey, James B. Seward, Mayo Clinic, 
Rochester. MN 
Background: Stroke is a major cause of disability and mortality in the elderly Accurate 
risk stratification is pivotal for containment of this major public health problem. 
Methods: The study included residents of Olmsted County, Minnesota, who underwent 
echocardiography between 1990-96 and at the time were t 65 years of age, in sinus 
rhythm, without valvular or congenital heart disease, prior stroke or atria.1 fibrillation. Clin- 
ical and echocardiographic characteristics were retneved from medical records. Left 
atrial volume, indexed to body surface area (LAVI) was measured offline. Multwarlate 
Cox propoftional hazards models for prediction of stroke were developed. The relative 
hazards associated with successively higher quartiles of age-adjusted left atrial dimen- 
sion (LAD) and LAVl were determined with Cox proportional hazards modeling, starting 
with a ‘saturated model’ and an assumption that a change in risk occurred with each 
quartile increment. The least significant jumps wars deleted in succession until all terms 
were significant at p ~0.05. 
Results: Amongst 1459 patients (mean age 75+7 years; 38% male) who met the study 
criteria, incident stroke occurred in 102 patients (7%) over mean follow-up time of 4.2 * 
3.6 years. Univariate predictors of stroke were age, hypertension, heart failure, myocar- 
dial infarction (Ml), diabetes mellitus (DM), carotid artery disease, transient ischemic 
attack (TIA), LAVI. LAD, left ventricular (LV) wall thickness, and LV fractlonal shortening. 
887FO-4 Platelet Function in the Elderly: The Difference Between 
Stable and Unstable Angina 
John R. Gilstad, Ross E. Anderson, Kewn P. Bliden, Paul A. Gurbel, Sinai Center for 
Thrombosis Research, Baltimore, MD, Johns Hopkins University School of Medicme, 
Baltimore, MD 
Background: The functional status of platelets in older patients with acute coronary syn- 
dromes (ACS) may be reduced, in contrast to increased platelet activity seen in stable 
older subjects. Methods: Platelet functional status was assessed using light-transmlt- 
tance aggregometry with ADP and flow cytometric assay of platelet surface membrane 
markers in 55 patients presenting with ACS and 41 patients presenting with stable 
angina each of whom had demographic and medication data recorded. Multiple regres- 
sion analysis on each platelet function variable was used to define independent predic- 
tors. Results: Patients ranged in age from 38 to 92 years with a mean of 66. Aggregation 
was found to decrease with advancing age, but only among the ACS patients. In multi- 
variate analysis. age was the best predictor of decreased aggregation (Beta = -.556, 12 
=.353, p<O.OOl) among the patients with ACS Age was also the best predicator of 
decline in platelet labeling with PAC.I, an antibody against the GP llbillla active site 
(Beta=-,561, r2=.276, p=<.OOl) and of decline in platelet surface P-selectin (Beta=-,442, 
r2=240, p=<.OOl). Age did not predict total GPllblllla expression in either ACS or stable 
patients, nor platelet-leukocyte aggregates (co-labeling with antibody to CD 151 and CD 
14). Conclusion: In older patients with ACS there is decreased platelet actiwty at pre- 
sentation, indicated by an age-related decrease in ADP aggregation and decreased 
platelet surface expression of the active conformation of GPllb/llla and P-selectin. The 
absence of an age-related decrease in expression of total GPllblllla, and of platelet-leu- 
kocyte aggregates, suggests a complex interaction between age and platelet physiology. 
Decreased activation of GPllb/llla in older patients with ACS may relate to the observed 
increase in hemorrhagic complications in the elderly following llbillla inhibitors therapy, 
as well as thrombolytic therapy, and suggests a rationale for age-adjusting the dosage of 
these drugs. 
11:30 a.m. 
887FO-5 Reduced Aortic Distensibility and Congestive Heart 
Failure Among the Elderly in a Population-Based Study: 
The Cardiovascular Health Study 
Dalane W. Kitzman, John S. Gottdiener. Gerard P Aurigemma, Alice M. Arnold, Cheryl 
Egher. Karen Fowls, Jeffrey C. Hill, Wake Forest University School of Medicine, Winston 
Salem, NC, St. Francis Hospital, New York, NY 
Background: Thoracic aortic distensibility (AOD) decreases with aging and is a major 
determinant of left ventricular &e&ad. Several lines of ewdence suggest that an exag- 
gerated reduction in AOD may play a role in heart failure (HF) in the elderly, the malority 
of whom have preserved systolic function. Methods: We examined AOD by echocardio- 
graphy in a case-control analysis of 657 participants (pts) (438 HF pts and 419 controls) 
in the population-based Cardiovascular Health Study. Results: pts were 76*6 years old 
(range 66-99), and 52% were women. Age-adjusted mean (+ se) AOD was 1.30 X 10-3 
(* 0.12 X 10-3) mmHg-1 in normal pts without cardiovascular disease (CVD). 1.02 x IO-3 
(+ 0.08 X 10-3) in pts with subclinical CVD, 0.83 x 10-3 (i 0.14 X 10-3) rn pts with estab- 
lished CVD but not HF, and 0.77 x 10-3 (+ 0.06 X 10-3) in pts with HF (p<O.OOl, differ- 
ence acmss groups). Thus, there was a stepwise decrease in a&c distensibility with 
increasmg CV disease burden. The reduction in AOD was similar in HF pts with pre- 
served vs. reduced systolic function. Reduced AOD was significantly associated with 
prevalent HF (at the time of the echo) and was a significant predictor of the development 
of incident HF over 3 years of follow-up (odds ratio 1.3 per std dev for both, confidence 
llmlts 1 .1-l .5, p <O.Ol, adjusted for age and gender). When the components of AOD 
were examined in paired analysis models, phasic aoltlc change yielded information 
regarding HF that was independent of pulse pressure. Conclusion: Aortic distensibility is 
reduced among elderly pts with either diastolic HF or systolic HF and is a significant prs- 
dictor of incident HF. Aortic stiffening may play a role in the development of HF I” the eld- 
erly. 
11:45 a.m. 
887FO-8 Elderly Patients Have Better Functioning, Less Angina 
at One Year With Coronary Artery Bypass Graft 
Karen P. Alexander, Barbara Lyile, Yun LI, Eric Peterson, Duke Clinical Research 
Institute. Durham, NC 
Background: Elderly pts facing CABG or PCI are concerned with quality as well as 
quantity of life. Yet, there is limited empirical data regarding longitudinal functional out- 
comes in elderly pts. 
Methods: We evaluated 1,058 pts aged > 70 yrs (mean 76 yrs) with significant CAD at 
cardiac catheterization from 8/98 to 4/ 01 at Duke. We compared baseline and 1 yr status 
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by initial treatment strategy (MED, PCI, CABG) using SF-36 physical function, health util- 
ity and Seattle angina questionnaire. Linear modeling to predict 1 year physical function 
(SF-36 PF) included pt characteristics and treatment strategy. 
Results: PCI was the initial treatment strategy in 41%, CABG 22% and MED 37% I” eld- 
erly CAD pts. Survival at 1 yr was highest among pts undergolng CABG (60% CABG, 
72% PCI, 50% MED). Pts undergoing CABG also had less angina, higher health utility 
rating, and better physical functioning at 1 yr than those treated with either PCI or MED 
(Table). CABG remained a significant predlctor (p=O.OOl) of higher 1 yr physical function 
(PF) even after adjusting for baseline PF. age, gender, education, prior MI, DM, PVD, 
EF, CAD severity and other predictors. In contrast, pts undergoing PCI had a non-signifi- 
cant trend toward better physical functioning at 1 year. 
Conclusions: After adjusting for potential confounders, CABG still affords elderly pts 
significantly better angma relief and funchonal outcomes at 1 year than either MED or 
IO:45 a.m. 
888-2 The Relationship Between B-Type Natriuretic Peptide, 
Heart Structure, and Function in 4,300 Patients With 
Heart Failure Enrolled to Val-HeFT 
Roberto Latini, Serge Masson, Lidia Staszewsky, Aldo P. Maggioni, Albert0 Volpi, 
Simona Barlera, lnderjit S. Anand, Allen Hester, Maylene Wang, Jay N. Cohn, on the 
behalf of Val-HeFT Investigators, lstituto Mario Negri, Milan, Italy. Uwersity of 
Minnesota, Minneapolis, MN 
Background: Although BNP is released from the heart and is elevated in heart failure 
(HF), the relation between LV ejection fraction (EF) and diameter (LVIDd) and BNP lev- 
els have not been adequately described. Methods: Val-HeFT (Valsartan Heart Failure 
Trial) was a randomized, double-blind, placebo-controlled trial in 5,010 pts on precribed 
therapy for HF. Plasma BNP was measured by IRMA in 2 core labs at baseline and dur- 
mg follow-up. Echocardiographic examinations were performed and read in individual 
centers. with centralized QC. At baseline, 4,300 pts were divided by quartiles (a) of EF or 
LVIDd. 3,696 pts had paired measurements of BNP. EF and LVlDd at baseline and 4 
months. Results: At baseline, BNP was significantly higher in pts with depressed EF 
(246+9 pg/mL for pts in Ql vs. 122+3 pg/mL in Q4). BNP was also higher in pts with LV 
dilation (119i5 pg/mL for pts in Ql vs. 256+9 pg/mL in Q4). *-month changes in BNP 
were similarly related to those in EF and LVIDd: pts with 25% increase in EF or > 0.5 cm 
decrease in LVlDd showed a median change in BNP of -12 and -13 pg/mL. a significantly 
greater decrease than in pts with less favorable changes in EF (-5 pg/mL, p= 0.0002) and 
LVlDd (-5 pglmL, p= 0.0004). Conclusion: Baseline BNP is a marker of altered baseline 
LV structure and function in HF. Changes in BNP at 4 months from baseline reflect those 
of EF and LVIDd. 
PCI without excess mortality. 
Health Outcomes by Treatment 
MED PCI CABG 
Angina (%) 
Health Utility (l-100) 
Physical Function (mean) 
Baseline 49 
1 -year 26 
Baseline 61 
1 -year 63 
Baseline 44 
1 -year 51 
47 47 
23 13 
65 62 
67 70 
54 56 
54 65 
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888-l Obesity Influences the Accuracy of B-Type Natriuretic 
Peptide Measurement in Chronic Heart Failure 
Mandeep Ft. Mehra. Patricia A. Uber, Pablo F. Nasca, Bobbette C. Harris, Myung H 
Park, Robert L. Scott, Ochsner Clinic Foundation, New Orleans, LA 
Background: Since adipose cells express clearance receptors for natriuretic peptides, 
we evaluated the influence of obesity in measurement of b-type natriuretic peptide (BNP) 
levels in systolic heart failure (HF). 
Methods and Results: We studied 237 consecutive patients (age 56 * 13 years, 63% 
men and 50% African American) with chronic systolic HF (LVEF 24 * 10 %) optimally 
treated with neurohormonal blockade (91% ACEI or ARB and 75% beta blockers). Step- 
wise regression modeling was used to assess the relationship of body mass index (BMI) 
and BNP levels while controlling for demographic variables (age, race and gender), 
structural indices (LVEF and end diastolic diameter), severity of heart failure (NYHA 
class, lean body mass corrected peak VO,), and creatinine. The mean BMI was 29.3 f 
6.4 kg/m2 and 120 patients (51%) were obese with a BMI > 30 kg/m2. Despite similar 
functIonal class, LVEF, lean VC$, and renal function, BNP levels were significantly lower 
in obese subjects than non-obese. 
Group NYHA Class LVEF% LeanVO, SCr BNP (pg/ml) 
Non- 2.2 * 0.7 23 zt 9 23 * 9 1.3iO.7 402258 
Obese 
Obese 2.1 * 0.6 24210 23 * 5 1.320.4 263*23 
pvatue ns “s “s ns 0.009 
(Lean VO, in cclkglmin, Serum creatmine in mg/dl) 
Stepwise regression identified lower BMI. lower LVEF, worse NYHA class, African Amer- 
ican race and age as independent predictors of higher BNP levels. 
Conclusions: This investigation estabkshes obesity as an independent modifier of BNP 
levels I” chrome systolic HF. Thus, these findings not only point to obesity as a regulator 
of endogenous natriuretic peptides in HF but also imply that lower natriuretic peptide lev- 
els might suggest worse severity of HF in the obese. 
11 :oo a.m. 
888-3 Prevalence and Clinical Characteristics of Patients With 
Chronic Systolic Heart Failure and Normal Plasma 
Levels of B-Type Natriuretic Peptide 
W.H. Wilson Tang, John P. Girod, Michael J. Lee, Randall C. Starling, James B. Young, 
Gary S. Francis, The Cleveland Clinic Foundation, Cleveland, OH 
Backgrountt Despite the high negative predictive value of plasma B-type natriuretic 
peptide (BNP) in excluding a cardiac source of dyspnea. some patients with established 
chronic systolic heart failure have low plasma levels of BNP. We examine the prevalence 
and clinical characteristics of this patient cohort in a ‘“real world” practice setting. Meth- 
ods: We followed 269 consecutive patients with chronic systolic heari failure (LVEF 
c40%, NYHA II-IV, 51% ischemic) seen at the Cleveland Clinic outpatient heart failure 
clinic between 1 l/01 -6102. Retrospective chart review was performed to determine clini- 
cal, functional and echocardiographic data. Plasma BNP levels were determined by the 
Biosite Triage BNP assay with a standard cut-off point of 100 pg/mL. Clinical characteris- 
tics between patients with plasma BNP cl00 pg/mL and those ~100 pg/mL were com- 
pared usina univariate analvses.Resultr 54 oatients (19 %) have “normal” olasma BNP 
levels cl00 pg/mL, among them 31 (57%) had BNP = 50 pg/mL. Compared to those with 
BNP =lOO oo/mL. oatients with “normalll BNP levels were vounoer and more likelv to ._ I  _  
have non-ischemic etiology (79% vs 35%, p<O.OOl). They had higher LV ejection fraction 
(LVEF 29% vs 23%, p<O.OOl), lower LV end-diastolic dimension (LVIDd 58mm vs 62mm, 
p=O.OOS), and less comorbidities (atrial fibrillation 27% vs 60%, renal dysfunction 14% vs 
49%, p<O.OOl). However, age, gender, history of hypertension, presence of diastolic dys- 
function, and treatment patterns were similar between the two groups. Overall. plasma 
BNP levels were lower in patients with non-ischemic versus ischemic etiology (338 +I86 
vs 527 +181 oa/mL. ocO.oOll. even after adiustments for aae. sender. LVEF. LVIDd. ._ - _ 
renal function, and NYHA class.Conclusion: Up to one-fifth of patients with chronic sys- 
tolic heart failure demonstrate olasma BNP levels below 100 oo/mL. Althouoh lower BNP 
levels correlated with less cardiac remodeling and less comorbid conditions (as 
expected), non-ischemic cardiomyopathy predominates in this “normal” BNP cohort. It is 
conceivable that the heterogeneity of BNP expression and elimination may affect the 
interpretation of plasma BNP levels in patients with chronic systolic heart failure. 
